Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spinifex appoints Declan Doogan non-executive chair

This article was originally published in Scrip

Executive Summary

Spinifex Pharmaceuticals, an Australian pain drug development company, has appointed Dr Declan Doogan, who has 30 years' experience of the pharmaceuticals industry, non-executive chair. Dr Doogan is currently chief medical officer of Amarin Corporation and served as interim CEO of the company from 2009-10. Prior to joining Amarin in 2007, Dr Doogan spent 20 years at Pfizer, most recently as senior vice-president and head of worldwide development.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel